119 related articles for article (PubMed ID: 10023018)
1. L-myc genotypes in Hong Kong Chinese colorectal carcinoma patients.
Ko JM; Cheung MH; Wong C; Lau K; Tang CM; Kwan MW; Lung ML
Oncol Rep; 1999; 6(2):441-4. PubMed ID: 10023018
[TBL] [Abstract][Full Text] [Related]
2. Genomic instability and alterations in Apc, Mcc and Dcc in Hong Kong patients with colorectal carcinoma.
Ko JM; Cheung MH; Kwan MW; Wong CM; Lau KW; Tang CM; Lung ML
Int J Cancer; 1999 Aug; 84(4):404-9. PubMed ID: 10404094
[TBL] [Abstract][Full Text] [Related]
3. [Association between H-ras and L-myc gene polymorphisms and susceptibility to colorectal cancer].
Ni Q; Zhang YJ; Zhang SC; Jin MJ; Ma XY; Yao KY; Li QL; Chen K
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):15-20. PubMed ID: 22490849
[TBL] [Abstract][Full Text] [Related]
4. Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations.
Gao J; Pfeifer D; He LJ; Qiao F; Zhang Z; Arbman G; Wang ZL; Jia CR; Carstensen J; Sun XF
Scand J Gastroenterol; 2007 Mar; 42(3):345-50. PubMed ID: 17354114
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers.
Jernvall P; Mäkinen MJ; Karttunen TJ; Mäkelä J; Vihko P
Br J Cancer; 1999 Feb; 79(5-6):903-8. PubMed ID: 10070888
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of the c-myc proto-oncogene in colorectal carcinoma.
Smith DR; Myint T; Goh HS
Br J Cancer; 1993 Aug; 68(2):407-13. PubMed ID: 8347498
[TBL] [Abstract][Full Text] [Related]
7. [A study on the loss of heterozygosity at the APC/MCC and DCC genetic loci in colorectal cancers].
Lui Y; Fang D; Lu R
Zhonghua Nei Ke Za Zhi; 1996 Jul; 35(7):439-43. PubMed ID: 9592312
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
[TBL] [Abstract][Full Text] [Related]
9. p53 mutations detected in colorectal carcinoma patients in Hong Kong.
Leung CS; Cheung MH; Wong CM; Lau KW; Tang CM; Lung ML
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):925-30. PubMed ID: 9367066
[TBL] [Abstract][Full Text] [Related]
10. Comparative p53 mutational spectra in aerodigestive tract tumors in Hong Kong Chinese patients.
Chan WC; Leung CS; Lung ML
Oncol Rep; 1999; 6(1):167-72. PubMed ID: 9864422
[TBL] [Abstract][Full Text] [Related]
11. Ki-ras codon 12 point mutational activation in Hong Kong colorectal carcinoma patients.
Ko JM; Cheung MH; Wong CM; Lau KW; Tang CM; Kwan MW; Lung ML
Cancer Lett; 1998 Dec; 134(2):169-76. PubMed ID: 10025877
[TBL] [Abstract][Full Text] [Related]
12. Analysis of L-myc and GSTM1 genotypes in Chinese non-small cell lung carcinoma patients.
Ge H; Lam WK; Lee J; Wong MP; Yew WW; Lung ML
Lung Cancer; 1996 Nov; 15(3):355-66. PubMed ID: 8959680
[TBL] [Abstract][Full Text] [Related]
13. A newly identified pattern of K-ras mutations at codons 12 and 13 is associated with long-term survival in colorectal cancer.
Senagore AJ; Biener JT
Surgery; 1997 Oct; 122(4):765-70. PubMed ID: 9347854
[TBL] [Abstract][Full Text] [Related]
14. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
[TBL] [Abstract][Full Text] [Related]
15. Activation of the ras genes in malignant and premalignant colorectal tumors.
Glarakis IS; Savva S; Spandidos DA
Oncol Rep; 1998; 5(6):1451-4. PubMed ID: 9769386
[TBL] [Abstract][Full Text] [Related]
16. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
Yaylim I; Isbir T; Oztürk O; Turna A; Işitmangil T; Zonüzi F; Camlica H
Cancer Genet Cytogenet; 2002 Apr; 134(2):118-22. PubMed ID: 12034523
[TBL] [Abstract][Full Text] [Related]
17. Molecular staging of colorectal cancer: a step forward.
Liefers GJ; Tollenar RA; Cleton-Jansen AM
Gastroenterology; 1999 Mar; 116(3):769-70. PubMed ID: 10094604
[No Abstract] [Full Text] [Related]
18. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients.
Chen J; Guo F; Shi X; Zhang L; Zhang A; Jin H; He Y
BMC Cancer; 2014 Nov; 14():802. PubMed ID: 25367198
[TBL] [Abstract][Full Text] [Related]
19. Allelic imbalance at an 8q24 oncogenic SNP is involved in activating MYC in human colorectal cancer.
Sugimachi K; Niida A; Yamamoto K; Shimamura T; Imoto S; Iinuma H; Shinden Y; Eguchi H; Sudo T; Watanabe M; Tanaka J; Kudo S; Hase K; Kusunoki M; Yamada K; Shimada Y; Sugihara K; Maehara Y; Miyano S; Mori M; Mimori K
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S515-21. PubMed ID: 24390711
[TBL] [Abstract][Full Text] [Related]
20. Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas.
Vortmeyer AO; Lubensky IA; Merino MJ; Wang CY; Pham T; Furth EE; Zhuang Z
J Natl Cancer Inst; 1997 Oct; 89(19):1448-53. PubMed ID: 9326914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
